The article suggests that research challenging the evidence for ADHD drugs does not lead to changes without public campaigns.
A new article discusses the lack of research dedicated to discontinuing psychiatric drugs and reviews existing strategies.
After 15 years, the founder of SurvivingAntidepressants.org, Adele Framer, shares what she has learned about the science of withdrawing from psychiatric drugs.
Adverse physiological symptoms of antidepressant withdrawal are regularly mistaken to be other problems to the detriment of the patient.
Bias and financial conflicts in antidepressant trials “contribute to systematic underestimation of risk in the published literature.”
Due to lackluster antidepressant study results, researchers test if subgroups of depressed patients show greater improvement.
Qualitative study finds that both internal resources and systemic factors play a role in antipsychotic discontinuation outcomes.
People with "serious mental illness" who stop taking antipsychotics are more likely to recover, even when accounting for baseline severity.
Protracted Withdrawal Syndrome characterized by long-term adverse experiences after coming off of antidepressants.
An analysis of FDA adverse event reports related to esketamine shows the potential for negative effects such as suicidal and self-injurious ideation.
New research finds that antidepressants are not effective for bipolar disorder and can worsen symptoms of mania.
A new study looks at how online communities provide information and support for patients experiencing psychiatric drug withdrawal.
MIA's Emaline Friedman interviews legal scholar Piers Gooding on his work on disability rights and digital mental health technologies.
Patient advocates join with researchers and service users to present first-hand experiences of antidepressant withdrawal.
Researchers investigate the claim that the introduction of antidepressant drugs led to decreases in suicide rates internationally.
According to researchers, children are being increasingly prescribed multiple different psychiatric medications.
A new study offers promising results for psilocybin-assisted psychotherapy for depression.
Noted antidepressant researcher, Michael Hengartner, summarizes the latest research on the use of antidepressants in children and adolescents.
A new study finds that anticholinergic drugs, like antidepressants and antipsychotics, are associated with mild cognitive decline.
Researchers review a new synthesis of the existing evidence and conclude that the harms of antidepressants outweigh any benefits.
A new study finds that adding an antipsychotic to existing antidepressant treatment is associated with a 45% increased risk of early death.
A new study finds adverse long-term consequences associated with the increased use of antipsychotics in first-episode psychosis.
Royal College of Psychiatrists’ former president demands support for patients coming off antidepressants.
Taking an SSRI antidepressant was associated with a 26% increased risk of violent crime conviction.
Studies that compare the effectiveness of different antidepressant drugs are unreliable, according to new research in BMC Psychiatry.